Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
|Articles|October 25, 2021

Advarra Announces Site IQ

Advarra has announced the launch of Site IQ. The platform builds on Advarra's experience as the provider of practice management solutions for clinical research to deliver an integrated set of site and principal investigator insights to enable smarter site selection. The Site IQ platform provides customized data analysis to help sponsors and CROs make informed decisions in their investigative site selection and feasibility processes.

Advarra Site IQ delivers insights to drive study startup by supporting protocol planning and site selection processes. Site IQ informs intelligent site selection by leveraging comprehensive data across experience, capacity, quality, performance, and patient eligibility. Data is derived from Advarra's data as well as third-party partner data. As such, Site IQ reflects insights based on actual study and performance data, not estimates or self-reported information.


Related to this article

Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.